2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)

Authors

  • Fred Saad Centre Hospitalier de l’Université de Montréal
  • Armen Aprikian McGill University Health Centre
  • Antonio Finelli Division of Urology, University of Toronto
  • Neil E. Fleshner Division of Urology, University of Toronto
  • Martin Gleave Department of Urological Sciences, University of British Columbia
  • Anil Kapoor Division of Urology, Department of Surgery, McMaster University
  • Tamim Niazi Jewish General Hospital, Montreal
  • Scott A. North Department of Medical Oncology, University of Alberta
  • Fréderic Pouliot CHU de Quebec, Université Laval
  • Ricardo A. Rendon Department of Urology, Dalhousie University
  • Bobby Shayegan Division of Urology, Department of Surgery, McMaster University
  • Srikala S. Sridhar Division of Medical Oncology, University of Toronto
  • Alan I. So Department of Urologic Sciences, University of British Columbia
  • Nawaid Usmani Department of Oncology, Division of Radiation Oncology, University of Alberta
  • Eric Vigneault Department of Radiation Oncology, CHU de Quebec, Université Laval
  • Kim N. Chi BC Cancer Agency, Vancouver

DOI:

https://doi.org/10.5489/cuaj.8161

Keywords:

CRPC, guideline

Downloads

Download data is not yet available.

Published

2022-10-27

How to Cite

Saad, F., Aprikian, A., Finelli, A. ., Fleshner, N. E. ., Gleave, M. ., Kapoor, A., Niazi, T. ., North, S. A., Pouliot, F. ., Rendon, R. A. ., Shayegan, B., Sridhar, S. S. ., So, A. I., Usmani, N. ., Vigneault, E. ., & Chi, K. N. (2022). 2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC). Canadian Urological Association Journal, 16(11), E506–15. https://doi.org/10.5489/cuaj.8161

Issue

Section

CUA Guideline